VOLUME 17 | NUMBER 12 | DECEMBER 2011 nature medicine t e c h n i c a l r e p o r t s Advancing understanding of human coronary artery disease requires new methods that can be used in patients for studying atherosclerotic plaque microstructure in relation to the molecular mechanisms that underlie its initiation, progression and clinical complications, including myocardial infarction and sudden cardiac death. Here we report a dual-modality intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo using a combination of optical frequency domain imaging (OFDI) and near-infrared fluorescence (NIRF) imaging. By providing simultaneous molecular information in the context of the surrounding tissue microstructure, this new catheter could provide new opportunities for investigating coronary atherosclerosis and stent healing and for identifying high-risk biological and structural coronary arterial plaques in vivo.
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Atherosclerosis is an inflammatory, progressive disease of the arteries that accounts for the majority of deaths in the United States 1 . One of the major contributors to this high mortality rate is coronary artery disease (CAD), characterized by the buildup of atherosclerotic plaques in the coronary wall. These lesions can progress over time and may eventually precipitate clot formation (thrombosis), leading to heart attack (myocardial infarction) and sudden cardiac death. Owing to the high prevalence of CAD, it is imperative that new in vivo tools are developed to investigate how coronary plaques evolve, disrupt blood flow and cause heart attacks, as well as how they respond to different forms of treatment.
Because many of the underlying structural and molecular mechanisms involved in CAD occur on a microscopic scale, catheter-based high-resolution imaging techniques are ideal candidates for research and diagnosis in patients. OFDI 2 , also known as frequency-domain optical coherence tomography (FD-OCT) [3] [4] [5] [6] , has been shown to rapidly acquire three-dimensional images of the artery wall at a microscopic resolution in a few seconds 2, 7 . Owing to its superior resolution and high frame rates, intracoronary OFDI has now emerged as one of the most promising new clinical methods for interrogating the microstructural detail of the coronary wall 7, 8 .
In addition, complementary cellular and molecular information in arterial disease, such as inflammatory protease activity, the macrophage composition of the inflammatory infiltrate, upregulated vascular cell adhesion molecules and the presence or absence of fibrin, may be obtained by NIRF molecular imaging approaches [9] [10] [11] [12] [13] . Recently, an intravascular NIRF sensing approach has been successfully demonstrated for one-dimensional intravascular detection of atheroma inflammation in coronary-sized vessels in vivo using a proteaseactivatable NIRF agent 9 . The two techniques of OFDI and NIRF have been independently established, but combination of both technologies in a single coronary catheter would greatly enhance their utility by visualizing molecular detail, precisely co-registered onto the microscopic architectural morphology of the artery wall, including following implantation of bare metal or drug-coated stents. Here we present new catheter-based, dual-modality, intra-arterial images simultaneously obtained with fully co-registered OFDI and NIRF in vivo.
RESULTS

Dual-modality catheter imaging system
We conducted coincident microstructural and fluorescent molecular imaging with a dual-modality catheter system developed in our laboratory ( Fig. 1) . The catheter's outer transparent sheath (800-µm diameter; 2.4 F) was the same as that used in ongoing single-modality OFDI clinical studies 7 , thus facilitating the translation of this technology to patients in the future. We constructed a unique optical imaging probe, contained in the catheter's sheath, from a double-clad fiber with a single-mode core that transmits and receives the OFDI light and a multi-mode light-guiding inner cladding that transmits the NIRF excitation and receives the emitted fluorescence light 14 (Supplementary Fig. 1a) . A side-viewing ball lens, fabricated at the distal end of the fiber (Supplementary Fig. 1b,c) , provided focused, co-registered OFDI and NIRF excitation spots in the artery wall.
We obtained an OFDI depth profile (A-line) of the tissue's microstructure and a single fluorescence emission value at each imaging Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo probe position. We obtained three-dimensional microstructural OFDI and two-dimensional NIRF data simultaneously by helical pullback scanning of the imaging probe in the transparent catheter sheath ( Supplementary Video 1 and Supplementary Methods) . The dual-modality system developed for the study provided microscopic cross-sectional OFDI images (~7-µm axial resolution, ~30-µm transverse resolution) of tissue structure with a high frame rate (25.4 frames per second (f.p.s.) with 2,048 radial scans per image), a long ranging depth (4.6 mm in saline) and a high sensitivity (110 dB). As with other optical techniques, the penetration depth of both OFDI and NIRF are limited, but these techniques are still capable of obtaining detailed information on the first several millimeters of the artery wall.
The system simultaneously acquired molecular information from nearinfrared (NIR) fluorochromes with a lateral resolution of approximately 100 µm at a sampling rate equal to the A-line acquisition rate of OFDI (52 kHz). The NIRF provided highly sensitive detection of <1 nM Cy7 NIR fluorochrome and showed a linear relationship to the concentration of the fluorochrome. We quantified fluorochrome concentration on OFDI-NIRF images using both titration and distance calibration studies ( Supplementary Fig. 2 and Supplementary Methods). We rendered the OFDI data for three-dimensional visualization by segmenting the luminal wall 15 , stent struts 16 and thrombus 17 using previously established criteria for optical coherence tomography (OCT) image characterization 7 , and fused the data from each modality by mapping the NIRF signal onto the volume-rendered OFDI data set ( Supplementary Fig. 3 and Supplementary Methods). We measured the variation of the co-registration of OFDI and NIRF as <10 µm in the rotational direction and 18 µm in the longitudinal direction ( Supplementary Fig. 4 and Supplementary Methods), which is below the lateral resolution of OFDI.
Intravascular imaging of stent microthrombosis
Stent microthrombosis was one of the models we chose to validate this technique because identification of fibrin coverage on stents may provide information on the future risk of clinical stent thrombosis 18, 19 . Although OFDI can identify large protruding thrombi on a structural basis 17 , the greater biological specificity and sensitivity afforded by NIRF molecular imaging of fibrin may enable specific discrimination of key thrombus-associated molecules that overlie stent struts following implantation, a capability that is currently not possible with standalone OCT or OFDI 20, 21 .
In our first experiment with the catheter, we performed dual-modality imaging of a cadaveric coronary artery with an implanted NIR fluorescent-fibrin labeled stent in vitro ( Fig. 2 and Supplementary Methods). Cross-sectional OFDI images of the stented cadaver coronary artery were comparable to standalone OFDI images 7 , clearly showing the microstructural detail of the arterial wall, the metallic stent struts and the thrombus ( Fig. 2a,b) . The simultaneously acquired intravascular NIRF data are shown as a cylinder, using maximum intensity projection volume rendering ( Fig. 2c) and are presented adjacent to fluorescence reflectance imaging (FRI) of the Figure 1 Schematic of the dual-modality intra-arterial catheter for simultaneous microstructural and molecular imaging using OFDI and NIRF. OFDI and NIRF systems are combined in one system by a dual-modality rotary junction that rotates and pulls back the imaging probe contained in the transparent catheter sheath, in a manner analogous to that used in standalone OCT, OFDI and mechanical scanning intravascular ultrasound. The imaging probe consists of a double-clad fiber that transmits OFDI and NIRF light through separate concentric light-guiding channels and focuses the beams into the sample. In the OFDI system, the light source changes its wavelength rapidly as a function of time. The depth profile (A-line) is reconstructed by taking the Fourier transform of the spectral interference signal that is generated when the reference and back-reflected signals from tissue microstructures are combined and detected. Depth profiles are continuously acquired to form cross-sectional images while the probe is rotating. NIR fluorescence emission, which reports molecular information, is also simultaneously acquired at every A-line acquisition. Scale bars, 100 µm. t e c h n i c a l r e p o r t s excised specimen ( Fig. 2d) . Side-by-side comparison of FRI and rendered three-dimensional NIRF showed that there is a good visual correspondence between the intravascular NIRF representation and the FRI standard 11 .
To demonstrate the potential of dual-modality intra-arterial imaging of stent microthrombi in vivo, we acquired three-dimensional data sets of a coronary stent that was covered by fluorescently labeled fibrin-rich thrombus, deployed in the right iliac artery of a New Zealand white (NZW) rabbit, and imaged in vivo. We successfully acquired comprehensive OFDI and NIRF data from a 12.5-mm segment of the iliac artery of a living NZW rabbit in 5 s with a frame interval of 100 µm. OFDI images showed the microstructure of the rabbit artery, including metallic stent struts and thrombus (Fig. 3a) . The simultaneously acquired NIRF signal (Fig. 3b) provided highly sensitive detection of the Cy7 NIR fluorochrome binding to fibrin. Comprehensive two-dimensional intra-arterial NIRF imaging provided sufficient spatial resolution to allow the visualization of stent struts (width = 81 µm) when surrounded by a strong fluorescent signal (Supplementary Fig. 5 ). When fused onto the luminal surfaces of the OFDI cross-sectional images, regions of the artery containing thrombi as identified by OFDI also showed strong fluorescence from Cy7-labeled fibrin 17 (Fig. 3c) . We detected NIRF signals in other portions of the artery that did not contain clear OFDI evidence of thrombus (yellow image, Fig. 3c) , indicating an enhanced fibrin sensitivity for NIRF molecular imaging.
Microscopic NIRF signal and fibrin-positive histology were highly correlated. The colocalization coefficients of OFDI-delineated thrombus and NIRF-labeled fibrin were measured to be 0.98 and 0.67, respectively ( Supplementary Fig. 6 and Supplementary Methods) . These coefficients, along with the results shown in Fig. 3 , can be explained by the presence of fibrin in nearly all OFDI-delineated thrombi and a higher sensitivity of NIRF for detecting fibrin than that of structural characterization by OFDI alone. Color-coded volume rendering (Fig. 3d ) and a flythrough movie (Supplementary Video 2) of the OFDI data with and without the NIRF overlay showed that OFDI-delineated thrombus and Cy7-labeled fibrin were highly colocalized in three dimensions as well. Dual-modality intravascular imaging of the control, unstented aorta of the same rabbit demonstrated negligible NIR fluorescence and indicates the absence of OFDI-delineated thrombus (Supplementary Fig. 7) .
Intravascular imaging of inflammation in atherosclerosis
To further demonstrate the clinical potential of dual-modality OFDI-NIRF imaging, we performed simultaneous imaging of atherosclerotic plaque morphology and inflammation-associated enzymatic activity in vivo. We generated atherosclerotic plaques in four NZW rabbits by combining balloon denudation in the right iliac artery and the aorta with a high-cholesterol diet (7-9 weeks). We injected the atheromabearing rabbits intravenously with a cysteine protease-activatable NIRF agent 24 h before imaging. The agent, validated in mouse and rabbit models of atherosclerosis, reports on the activity of cysteine proteases, including cathepsin B, in inflamed arteries 9, 22 . Using the dual-modality intra-arterial catheter, we acquired simultaneous OFDI and NIRF images of normal and atherosclerotic arteries from both iliac arteries Figure 3 Dual-modality OFDI-NIRF images of an iliac artery of a rabbit with an implanted NIR-fluorescent fibrin-coated stent, attained in vivo. (a) A representative cross-sectional image of OFDI data. OFDI shows the cross-sectional arterial microscopic architectural morphology, including thrombi (red arrows) and stent struts (yellow asterisks). (b) A corresponding one-dimensional plot of NIRF data that were simultaneously acquired with OFDI. The NIRF signal shows strong peaks where the thrombi were detected in OFDI (red arrows in a,b). The NIRF signal was negligible in areas that did not show OFDI evidence of thrombus or fibrin by histology (blue arrowhead in a,b). and the aorta in vivo. We obtained dual-modality images from a total of ten arteries: four in the aorta, three in the injured right iliac arteries and three in the noninjured left iliac arteries. We performed a total of three pullbacks in each artery. In two of the iliac arteries, we were unable to insert the catheter because of stenosis due to a high atherosclerotic burden, or because of anatomical constraints. We detected focal plaques by OFDI-NIRF in the data set acquired in 8 s from a 40-mm segment of the iliac artery ( Fig. 4) . Cross-sectional OFDI images showed the microstructure of the rabbit iliac artery with protruding focal plaque evident at the bottom right quadrant of the artery (Fig. 4a) . From the OFDI image, we characterized the focal plaque using morphological features, including a highly scattering, raised, thickening of the artery wall (Fig. 4a) overlying a signal-poor region that is consistent with lipidrich tissue 15 (Fig. 4a) . Co-localized NIRF obtained from the same region in vivo had a high NIR fluorescence signal, indicative of cysteine protease activity, whereas NIRF from other uninvolved portions of the artery wall was weak (Fig. 4b,c) . RAM-11 staining confirmed the OFDI findings of a plaque containing macrophages (Fig. 4d) . Fluorescence microscopy of atheroma sections and NIR fluorescence (red channel) showed a high degree of spatial correspondence with the NIRF signals obtained in vivo (Fig. 4e) . The cathepsin B signal was also high in the plaque, as seen by immunohistochemistry (Fig. 4f) , and the spatial pattern of cathepsin B staining corresponded to that of the NIRF signals obtained in vivo.
Notably, the NIRF signal in the plaque was heterogeneous, with higher fluorescence in some areas (Fig. 4c , green asterisk) compared to in others (Fig. 4c, blue asterisk) . This finding, confirmed by NIR fluorescence microscopy and cathepsin B immunohistochemistry (Fig. 4h,i) , suggests that there may be differences in protease production and activity across varying populations of macrophages in this atherosclerotic plaque. The fact that this heterogeneity of inflammatory protease activity cannot be appreciated by OFDI alone demonstrates the power of this combined modality to provide complementary information on the presence of atherosclerosis and microstructural morphology of plaque by OFDI and inflammatory protease activity by NIRF imaging.
We further validated this technique's capability to measure plaque microstructure and protease content by comparing multiple (n = 13) cross-sectional OFDI-NIRF images obtained in vivo from the four rabbits, with corresponding H&E and cathepsin B immunohistochemically stained histological sections ( Supplementary Fig. 8 and Supplementary Methods). Linear regression showed that OFDI and histological measurements of percentage plaque circumference were highly correlated (r = 0.97, P < 0.0001; Supplementary Fig. 8g) . We also found a high correlation between the average NIRF signal intensity and cathepsin B immunostain-positive percentage area (r = 0.82, P = 0.0004; Supplementary Fig. 8h) . To assess the reproducibility of dual-modality imaging in vivo, we compared corresponding OFDI-NIRF cross-sections from paired test-retest pullback data sets. OFDI measurements of percent plaque circumferences for test and retest pullbacks were highly correlated (r = 0.99, P < 0.0001; Supplementary Fig. 8i) , showing an excellent OFDI measurement reproducibility, similar to that previously reported in clinical OCT studies [23] [24] [25] . Likewise, values for the average NIRF signal intensity were highly repeatable (r = 0.93, P < 0.0001; Supplementary Fig. 8j) , demonstrating reproducible NIRF measurement of molecular activity.
DISCUSSION
The ability of this new technology to simultaneously provide colocalized microstructural and molecular functional image information Macrophage staining by RAM-11 did not vary significantly across the plaque. However, as with NIRF signals in vivo, fluorescence microscopy and immunohistochemistry for cathepsin B showed heterogeneous protease activity in the plaque, with a higher signal in one area (green asterisk) compared to that in another area (blue asterisk), similar to the pattern observed in the NIR fluorescence microscopic images in h. Scale bars, 500 µm (a,b,d-f) and 200 µm (c,g-i). t e c h n i c a l r e p o r t s could prove useful for future understanding and management of both coronary artery disease and vessel wall healing following coronary stent implantation. Inflammatory cells, including macrophages, identified by OFDI 7 can now be further characterized in vivo in terms of molecular expression and activity by use of cathepsin protease-activatable NIR fluorescent molecular beacons such as Prosense 9, 11 . This new capability could allow researchers to gain knowledge about macrophage activity patterns for distinct plaque types and in response to different pharmacological therapies. The ability of OFDI-NIRF to identify areas of active inflammation in the context of other microstructural features such as thin fibrous caps over lipid cores should increase the predictive ability of imaging for detecting vulnerable plaques in humans. Intraplaque angiogenesis, also implicated in vulnerable plaques 26 , could be imaged using near-infrared fluorescent molecular imaging agents targeted to integrins, such as α v β 3 (ref. 13 ).
Drug-eluting stents, commonly used to treat ischemic coronary disease, prevent restenosis by attenuating smooth muscle proliferation. These devices unintentionally may also prevent endothelial regrowth, leading to fibrin deposition 20 and uncommon, but devastating or fatal occurrences of stent thrombosis 18 . Although standalone intracoronary OCT and OFDI are currently being investigated for the evaluation of stent tissue coverage in patients 16, 21 , these imaging technologies are limited by their inability to determine whether the tissue overlying stent struts is composed of fibrin, platelets, neointima, endothelial or inflammatory cells. Simultaneous intra-arterial molecular structural imaging in a rapid, single pullback could provide this crucial information, which is required to determine whether patients who receive drug-coated stents need to remain on protracted anticlotting medications 18, 20, 21 to prevent these potential complications. It is likely that many of the research and clinical applications of this multimodality technology will soon be realized; the dual-modality catheter presented here is mechanically and structurally identical to standalone OFDI catheters currently used in the cardiac catheterization laboratory 7 ; furthermore, FDA-approved NIR fluorescence-imaging agents, such as indocyanine green, and molecular-activity agents in the regulatory approval pipeline, such as Prosense, are anticipated to be available for human coronary imaging in the near term.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
